KMT2A and acute myeloid leukemia: Additionally, the combination of SNDX-50469 and abemaciclib was also synergistically lethal against PD AML cells harboring MLL-AF9 or mtNPM1 plus mutant FLT3 (samples #4, #5, and #9) (Fig. S5D–F).